Co-treatment with quercetin and cisplatin synergistically inhibits proliferation, migration, and invasion and enhances apoptosis in HeLa and SiHa human cervical cancer cells by weakening matrix metallopeptidase 2 (MMP2), ezrin, P-glycoprotein, and methyltransferase-like 3 (METTL3) expressions [118]. This evidence concerns the gene METTL3 and cervical carcinoma.